Description |
Eudesmin ((-)-Eudesmin) impairs adipogenic differentiation via inhibition of S6K1 signaling pathway. Eudesmin possesses diverse therapeutic effects, including anti-tumor, anti-inflammatory, and anti-bacterial activities[1].
|
Target |
S6K1[1]
|
In Vitro |
Treatment of mesenchymal stem cells (MSCs) with Eudesmin (20, 40, and 80μM) disturbs adipogenesis via suppression of S6K1 signaling pathway. Eudesmin treatment inhibits activation and nuclear translocation of S6K1. S6K1-mediated phosphorylation of H2B at serine 36 (H2BS36p) is reduced upon Eudesmin treatment[1].
|
Density | 1.2±0.1 g/cm3 |
Boiling Point | 517.3±50.0 °C at 760 mmHg |
Flash Point | 209.8±30.0 °C |
Exact Mass | 386.172943 |
PSA | 55.38000 |
LogP | 3.08 |
Vapour Pressure | 0.0±1.3 mmHg at 25°C |
Storage condition | 2-8°C |